University of Texas Texas AM Investment Management Co. Sells 6,979 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Key Points

• The University of Texas Texas AM Investment Management Co. significantly reduced its stake in HCA Healthcare, selling 6,979 shares and now holding only 336 shares, representing a 95.4% decrease in their position.
• Multiple institutional investors, including Sanders Capital LLC and Northern Trust Corp, have increased their holdings in HCA Healthcare, suggesting a mixed response among investors regarding the stock's future.
• HCA Healthcare reported earnings of $6.84 per share, surpassing estimates and indicating a revenue growth of 6.4% year-over-year, alongside a notable quarterly dividend announcement of $0.72 per share.

University of Texas Texas AM Investment Management Co. reduced its position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 95.4% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 336 shares of the company's stock after selling 6,979 shares during the quarter. University of Texas Texas AM Investment Management Co.'s holdings in HCA Healthcare were worth $116,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also modified their holdings of the company. Sanders Capital LLC increased its holdings in HCA Healthcare by 1.0% in the fourth quarter. Sanders Capital LLC now owns 11,655,563 shares of the company's stock valued at $3,498,417,000 after purchasing an additional 116,826 shares during the last quarter. Geode Capital Management LLC increased its stake in shares of HCA Healthcare by 1.3% in the 4th quarter. Geode Capital Management LLC now owns 3,871,057 shares of the company's stock valued at $1,159,882,000 after acquiring an additional 50,321 shares during the last quarter. Capital World Investors increased its stake in HCA Healthcare by 0.7% in the fourth quarter. Capital World Investors now owns 2,928,452 shares of the company's stock valued at $878,975,000 after purchasing an additional 19,121 shares in the last quarter. Northern Trust Corp increased its stake in HCA Healthcare by 12.4% in the fourth quarter. Northern Trust Corp now owns 2,017,971 shares of the company's stock valued at $605,694,000 after purchasing an additional 223,248 shares in the last quarter. Finally, Nuveen Asset Management LLC increased its position in shares of HCA Healthcare by 4.5% in the 4th quarter. Nuveen Asset Management LLC now owns 1,865,771 shares of the company's stock valued at $560,011,000 after buying an additional 81,105 shares in the last quarter. 62.73% of the stock is owned by institutional investors.

Insider Buying and Selling

In other news, COO Jon M. Foster sold 15,698 shares of the firm's stock in a transaction on Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the completion of the transaction, the chief operating officer owned 12,646 shares of the company's stock, valued at approximately $4,670,420.72. This trade represents a 55.38% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 1.30% of the stock is currently owned by insiders.

HCA Healthcare Stock Performance

Shares of NYSE:HCA traded up $0.33 during trading on Thursday, reaching $355.39. 525,111 shares of the stock were exchanged, compared to its average volume of 1,604,494. The stock has a 50-day moving average price of $371.51 and a 200-day moving average price of $346.46. The firm has a market cap of $85.50 billion, a PE ratio of 14.94, a PEG ratio of 1.08 and a beta of 1.47. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $417.14. The company has a current ratio of 0.98, a quick ratio of 0.86 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The firm had revenue of $18.61 billion during the quarter, compared to the consensus estimate of $18.49 billion. During the same quarter in the previous year, the firm posted $5.50 EPS. The business's revenue for the quarter was up 6.4% compared to the same quarter last year. Research analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th will be issued a $0.72 dividend. The ex-dividend date of this dividend is Tuesday, September 16th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.81%. HCA Healthcare's dividend payout ratio (DPR) is currently 12.11%.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on HCA shares. Truist Financial increased their target price on HCA Healthcare from $390.00 to $415.00 and gave the stock a "buy" rating in a research note on Wednesday, July 16th. Guggenheim assumed coverage on HCA Healthcare in a research note on Wednesday, April 9th. They issued a "neutral" rating on the stock. Barclays decreased their price objective on HCA Healthcare from $416.00 to $390.00 and set an "overweight" rating for the company in a report on Monday. Royal Bank Of Canada set a $401.00 price target on shares of HCA Healthcare and gave the stock an "outperform" rating in a research note on Monday. Finally, Robert W. Baird reaffirmed a "neutral" rating and issued a $336.00 target price (down previously from $396.00) on shares of HCA Healthcare in a research report on Tuesday, April 15th. Nine equities research analysts have rated the stock with a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, HCA Healthcare presently has a consensus rating of "Moderate Buy" and an average target price of $396.46.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.